sc599
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2005 (NCT00210288)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Shigella dysenteriaeImmunity, active
Shigella dysenteriae immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sc599
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00210288 | Phase 2 | May 1, 2005 | Institut Pasteur, University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Institut Pasteur | Academic/Hospital | 1 | 1 | 1 | 2005 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2005 |
2 organizations
Page 1 / 1